{"componentChunkName":"component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-blog-core-templates-post-query-js","path":"/zh-Hant/reddit/r/investing/comments/kv332t/eli_lilly_up_20_after_donanemab_shows_clinical/","result":{"data":{"site":{"siteMetadata":{"title":"国外股市热门","author":"Buzzing.cc","description":"用中文浏览国外股票社区里的热门讨论","keywords":["buzzing","美股","股票","股市"],"siteUrl":"https://stocks.buzzing.cc","telegram":"@stocks_top","iconUrl":"https://stocks.buzzing.cc/avatar.png","defaultSocialImageUrl":null,"social":[{"name":"Reddit Stocks","url":"https://www.reddit.com/r/stocks","external":true},{"name":"Reddit Investing","url":"https://www.reddit.com/r/investing","external":true},{"name":"Charlie Bilello's twitter","url":"https://twitter.com/charliebilello","external":true},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true}],"menuLinks":[{"name":"每周精选","url":"/issues","external":null}],"disqus":null,"utterances":null}},"blogPost":{"id":"RedditPost-b654010d-2e04-53f5-b716-11483ccbd985","excerpt":" * Eli Lilly (NYSE:LLY\n   [https://seekingalpha.com/symbol/LLY?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link])\n   gains 20% in premarket on promising results\n   [https://seekingalpha.com/pr/18145426-lillys-donanemab-slows-clinical-decline-of…","body":"<!-- SC_OFF --><div class=\"md\"><ul>\n<li>Eli Lilly (NYSE:<a href=\"https://seekingalpha.com/symbol/LLY?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">LLY</a>) gains 20% in premarket on <a href=\"https://seekingalpha.com/pr/18145426-lillys-donanemab-slows-clinical-decline-of-alzheimers-disease-in-positive-phase-2-trial?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">promising results</a> from <a href=\"https://clinicaltrials.gov/ct2/show/NCT03367403?cond=trailblazer&amp;draw=2&amp;rank=1&amp;source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">Phase 2 TRAILBLAZER-ALZ study</a>, evaluating donanemab, an antibody that targets a  modified form of beta amyloid called N3pG, for Alzheimer&#39;s disease  (AD). The study met the primary endpoint of change from baseline to 76  weeks in AD rating scale.</li>\n<li>Data  showed that donanemab slowed the decline in a composite measure of  cognition and daily function by 32%, compared to placebo.</li>\n<li>Safety profile was consistent with observations from Phase 1 data.</li>\n<li>Full  results of the TRAILBLAZER-ALZ study will be presented at a future  medical congress and submitted for publication in a peer-reviewed  clinical journal.</li>\n<li>Lilly plans to  discuss these results with regulators to assess next steps for  donanemab. In addition, TRAILBLAZER-EXT is an ongoing trial for those  who participated in TRAILBLAZER-ALZ.</li>\n<li>Safety, tolerability and efficacy of donanemab are also being evaluated in another <a href=\"https://clinicaltrials.gov/ct2/show/NCT04437511?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">Phase 2 study TRAILBLAZER-ALZ 2</a>.</li>\n<li>Progress on Alzheimer&#39;s treatments was one reason cited by BofA in picking Lilly as a <a href=\"https://seekingalpha.com/news/3649105-bofas-biopharma-picks-2021-set-to-build-new-launches-beatable-expectations?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">top name for 2021</a>.</li>\n</ul>\n\n<p><a href=\"https://seekingalpha.com/news/3650196-eli-lilly-up-20-after-donanemab-shows-clinical-benefit-in-mid-stage-alzheimers-study\">https://seekingalpha.com/news/3650196-eli-lilly-up-20-after-donanemab-shows-clinical-benefit-in-mid-stage-alzheimers-study</a></p>\n</div><!-- SC_ON -->","slug":"/reddit/r/investing/comments/kv332t/eli_lilly_up_20_after_donanemab_shows_clinical/","title":"Eli Lilly up 20% after donanemab shows clinical benefit in mid-stage Alzheimer's study","tags":["investing","reddit"],"date":"January 13, 2021","dateISO":"2021-01-13T00:11:37.000Z","datetime":"2021-01-13 00:11","image":null,"imageAlt":null,"socialImage":null,"__typename":"SocialMediaPost","thirdPartyId":"b654010d-2e04-53f5-b716-11483ccbd985","provider":"Reddit","url":"https://www.reddit.com/r/investing/comments/kv332t/eli_lilly_up_20_after_donanemab_shows_clinical/","originalUrl":"https://www.reddit.com/r/investing/comments/kv332t/eli_lilly_up_20_after_donanemab_shows_clinical/","imageRemote":null,"video":null,"channel":"investing","channelUrl":"https://www.reddit.com/r/investing","author":"Omg_Keynes","authorUrl":"https://www.reddit.com/user/Omg_Keynes","authorImage":null,"authorImageRemote":null,"authorSlug":"Omg_Keynes","score":35,"views":null,"sharedCount":null,"likeCount":null,"sharedContent":null,"parent":{"localize":[{"title":"Eli Lilly legt um 20% zu, nachdem Donanemab klinischen Nutzen in Alzheimer-Studie im mittleren Stadium zeigt","the_new_excerpt":" * Eli Lilly (NYSE:LLY\n   [https://seekingalpha.com/symbol/LLY?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link])\n   gewinnt 20% im vorbörslichen Handel aufgrund vielversprechender Ergebnisse\n   [https://seekingalpha.com/pr/18145426-lillys-donanemab-slows-clinical-decline-of...","locale":"zh"},{"title":"Eli Lilly legt um 20% zu, nachdem Donanemab klinischen Nutzen in Alzheimer-Studie im mittleren Stadium zeigt","the_new_excerpt":" * Eli Lilly (NYSE:LLY\n   [https://seekingalpha.com/symbol/LLY?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link])\n   gewinnt 20% im vorbörslichen Handel aufgrund vielversprechender Ergebnisse\n   [https://seekingalpha.com/pr/18145426-lillys-donanemab-slows-clinical-decline-of...","locale":"zh-Hant"}]}},"previous":{"id":"RedditPost-665db307-dc88-5d28-a7b3-e1de50dd032b","excerpt":"Stocks finish at all time highs to close out the first trading week of 2021.\nWhat is my opinion on the NIO stock after their latest event? DraftKings & PENN\nsoar after the latest New York developments, let’s talk about this and other\nstock market news\n\n~Very Long Post~\n\nHello everyone and Good…","slug":"/reddit/r/stocks/comments/kv249f/stock_market_news_for_today_nio_stock_news_dkng/","title":"Stock Market News for Today | NIO Stock News | DKNG, PENN & other Stock Market News [01-11]","date":"January 12, 2021","__typename":"SocialMediaPost","parent":{"localize":[{"title":"今日股市新闻|NIO股市新闻|DKNG、宾夕法尼亚等股市新闻[01-11]","the_new_excerpt":"股市收盘创下历史新高，结束了2021年的第一个交易周。\n在最近的事件之后，我对NIO的股票有什么看法？绘图国王和宾夕法尼亚\n在纽约最新的事态发展之后，让我们谈谈这个和那个\n股市消息\n\n~很长的帖子~\n\n大家好，好…","locale":"zh"},{"title":"今日股市新聞|NIO股市新聞|DKNG、賓夕法尼亞等股市新聞[01-11]","the_new_excerpt":"股市收盤創下歷史新高，結束了2021年的第一個交易周。\n在最近的事件之後，我對NIO的股票有什麼看法？繪圖國王和賓夕法尼亞\n在紐約最新的事態發展之後，讓我們談談這個和那個\n股市消息\n\n~很長的帖子~\n\n大家好，好…","locale":"zh-Hant"}]}},"next":{"id":"RedditPost-10d3b583-74da-522c-b05d-d33424117080","excerpt":"https://www.cnbc.com/2021/01/12/chinese-electric-car-start-up-xpeng-gets-2-billion-in-credit.html\n\nhuge support from three massive state owned banks to help build out its\nmanufacturing among other things. xpeng sets itself up nicely in another\nposition than nio. it'll be interesting to see how it…","slug":"/reddit/r/stocks/comments/kvtoly/xpeng_gets_2b_line_of_credit_from_chinese_state/","title":"Xpeng gets $2B line of credit from Chinese state owned banks (stock up 12% as of this post)","__typename":"SocialMediaPost","date":"January 13, 2021","parent":{"localize":[{"title":"讯鹏获得中国国有银行20亿美元信贷额度（截至本文发稿，股价上涨12%）。","the_new_excerpt":"https://www.cnbc.com/2021/01/12/chinese-electric-car-start-up-xpeng-gets-2-billion-in-credit.html\n\n三家大型国有银行的巨大支持，以帮助建立它的。\nxpeng在另一个方面为自己设定了很好的目标。\n这将是有趣的，看看它如何... ...","locale":"zh"},{"title":"訊鵬獲得中國國有銀行20億美元信貸額度（截至本文發稿，股價上漲12%）。","the_new_excerpt":"https://www.cnbc.com/2021/01/12/chinese-electric-car-start-up-xpeng-gets-2-billion-in-credit.html\n\n三家大型國有銀行的巨大支持，以幫助建立它的。\nxpeng在另一個方面爲自己設定了很好的目標。\n這將是有趣的，看看它如何... ...","locale":"zh-Hant"}]}}},"pageContext":{"basePath":"/","pageType":"detail","id":"RedditPost-b654010d-2e04-53f5-b716-11483ccbd985","previousId":"RedditPost-665db307-dc88-5d28-a7b3-e1de50dd032b","nextId":"RedditPost-10d3b583-74da-522c-b05d-d33424117080","maxWidth":1024,"siteMetadata":null,"locale":"zh-Hant","hrefLang":"zh-Hant","originalPath":"/reddit/r/investing/comments/kv332t/eli_lilly_up_20_after_donanemab_shows_clinical/","dateFormat":"YYYY-MM-DD"}},"staticQueryHashes":["1239077767","2744905544","3280999885"]}